| |
|
|
|
Kempharm Inc  
|
|
9.4 -0.37 (-0.04%) |
10-18 16:00 |
|
Open: |
9.76 |
Pre close: |
9.77 |
Target:
|
11.69
|
|
High: |
9.76 |
Low: |
9.26 |
Resistance:
|
10.01
11.69
|
|
Volume: |
501,436 |
Market Cap: |
268M |
Support:
|
9.11
8.56
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
9.68
 |
MACD |
MACD(12,26):
|
0.08  |
|
MA(20): |
9.22 |
Signal(12,26,9): |
-0.01 |
|
MA(100): |
10.69 |
Stochastic Oscillator |
%K(14,3):
|
71.65 |
|
MA(250): |
10.43 |
%D(3): |
79.38 |
|
Average Volume(K) |
3-Month: |
41868
|
52-Week |
High:
|
22.08 |
|
10-Days: |
28382 |
Low: |
5.07 |
|
RSI |
RSI(14):
|
51.93 |
Change(%): |
0.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-6.830 |
Return on Equity (ttm) |
-222.2 |
Shares Out. (M) |
28.51 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
6.4 |
Shares Float (M) |
24.56 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
14.73 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
480.0 |
% Held by Institutions |
16.03 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.420 |
Shares Short (K) |
3550 |
|
Book Value (p.s.) |
2.960 |
EBITDA (p.s.) |
0.189 |
P/E |
-1.38 |
|
Sales Per Share |
0.818 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.18 |
|
Profit Margin |
-74.21 |
Operating Cash Flow
(M) |
-2.50 |
P/S |
11.49 |
|
Operating Margin |
21.98 |
Levered Free Cash Flow
(M) |
-7.73 |
P/CF |
-107.20 |
|
|
|
|
|
|
